Salisbury Bancorp, Inc. Reports Results for First Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Salisbury Bancorp, Inc. Reports Results for First Quarter 2015; Declares 28 Cent Dividend

LAKEVILLE, Conn., April 24, 2015 (GLOBE NEWSWIRE) -- Salisbury Bancorp, Inc. ("Salisbury"), NASDAQ Capital Market: (Nasdaq: SAL ), the holding company for Salisbury Bank and Trust Company (the "Bank"), announced results for its first quarter ended March 31, 2015.

Net income available to common shareholders was $2,194,000, or $0.81 per common share, for the first quarter ended March 31, 2015 (first quarter 2015), compared with $196,000, or $0.10 per common share, for the fourth quarter ended December 31, 2014 (fourth quarter 2014), and $505,000, or $0.29 per common share, for the first quarter ended March 31, 2014 (first quarter 2014).

Selected First Quarter 2015 Financial Highlights

As a result of the acquisition being completed in December 2014, the results of Riverside's 2014 stand-alone operations are not reflected in the Salisbury information presented below.

  • Earnings per common share of $0.81 increased $0.71 versus fourth quarter 2014, and increased $0.52, versus first quarter 2014. The fourth quarter 2014 and first quarter 2014 included certain one-time expenses incurred in conjunction with strategic initiatives of $1,100,000 and $287,000 (after taxes), respectively. Excluding one-time expenses for fourth quarter 2014 and first quarter 2014, current earnings per share would have increased $0.13 and $0.35, respectively.
  • The net interest margin of 4.11% increased 43 basis points versus 3.68% for the fourth quarter 2014 and increased 39 basis points versus 3.72% for the first quarter 2014. Net loans receivable increased $3.4 million or 0.5% during the first calendar quarter of 2015 to $676.7 million, which reflects an increase of $230.2 million or 51.6%, from the end of the first quarter of 2014. The year-over-year increase includes $196.3 million of loans, recorded at fair value acquired, as a result of Salisbury's acquisition of Riverside Bank, completed in the fourth quarter 2014. The fair value adjustment represents the adjustment of the book value of acquired loans to their estimated fair value based on current interest rates and expected cash flows. These adjustments include an estimate of expected loan loss inherent in the acquired portfolio. Loans that met the criteria and are being accounted for in accordance with ASC 310-30 had an acquisition date book value of $13.7 million. Non-impaired loans not accounted for under ASC 310-30 had an acquisition date book value of $190.7 million.
  • Tax equivalent net interest income increased $2.2 million, or 36.4%, versus fourth quarter 2014, and increased $3.1 million, or 61.4%, versus first quarter 2014.

Richard J. Cantele, Jr., President and Chief Executive Officer, stated, "Salisbury Bank posted solid first quarter results, benefited by the fourth quarter merger with Riverside Bank. A stronger balance sheet and synergies achieved as a result of the merger were the primary drivers of those results. First quarter earnings also benefited from the $483,000 recovery of a previously charged off loan.

"Non-performing assets increased primarily as the result of two relationships migrating into the non-performing category during the quarter. Both of these relationships are secured by real estate, and both are continuing to make payments. We are working with the principals to reach resolution.

"Our team has made significant progress in the months following the merger, in terms of integrating staff, customers and systems. I expect our focus to remain on the successful integration of our companies over the next few quarters. We have simultaneously focused on increasing our commercial market presence in the Hudson Valley and delivering our residential mortgage and wealth management services, previously not offered by Riverside, to our customers."

Net-Interest Income

Tax equivalent net interest income for first quarter 2015 increased $2.2 million, or 36.4%, versus fourth quarter 2014, and increased $3.1 million or 61.4%, versus first quarter 2014. Average earning assets increased $149.7 million versus fourth quarter 2014, and increased $253.0 million versus first quarter 2014. Average total interest bearing deposits increased $101.0 million versus fourth quarter 2014 and increased $165.8 million versus first quarter 2014. The net interest margin of 4.11% increased 43 basis points versus 3.68% for the fourth quarter 2014 and increased 39 basis points versus 3.72% for the first quarter 2014.

Non-Interest Income

Non-interest income for first quarter 2015 increased $317,000 versus fourth quarter 2014 and increased $458,000 versus first quarter 2014. Trust and wealth advisory revenues increased $36,000 versus fourth quarter 2014 and increased $43,000 versus first quarter 2014. The increase is the result of higher estate fees collected in first quarter 2015, partially offset by a slight decrease in managed assets. Service charges and fees increased $66,000 versus fourth quarter 2014 and increased $189,000 versus first quarter 2014. The increases were a result of higher fees due to increased transactional volume, mainly attributable to the assumption of Riverside Bank deposits. Income from sales and servicing of mortgage loans increased $73,000 versus fourth quarter 2014 and increased $83,000 versus first quarter 2014 due to an increase in servicing values as a result of a decline in projected prepayment rates. First quarter 2015 mortgage loans sales totaled $2.1 million versus $0.9 million for fourth quarter 2014 and $0.5 million for first quarter 2014. First quarter 2015, fourth quarter 2014, and first quarter 2014 included a mortgage servicing valuation impairment benefit/(charge) of $9,000, ($1,000), and $11,000, respectively. Gain on sale of securities for the quarter totaled $175,000. No gains were recognized in either the fourth or first quarters of 2014. Other income includes bank owned life insurance income and rental income.

Non-Interest Expense

Non-interest expense for first quarter 2015 decreased $17,000 versus fourth quarter 2014 and increased $1.7 million versus first quarter 2014. Total compensation expense increased $53,000 versus fourth quarter 2014 as a result of higher salary and payroll tax expense offset by lower employee benefit costs. The total compensation expenses year-over-year increase of $960,000 is mainly attributable to increased staffing levels primarily as a result of the Riverside acquisition, mix, and annual increases.

Premises and equipment decreased $80,000 versus fourth quarter 2014 and increased $235,000 versus first quarter 2014. The increase in expense was related to the addition of branch facilities acquired as a result of the Riverside Bank acquisition, the Sharon, Connecticut branch acquisition, and the opening of a new branch in 2014 in Great Barrington, Massachusetts, as well as technology upgrades and seasonally influenced fuel and utility costs.

Data processing decreased $90,000 versus fourth quarter 2014 and increased $75,000 versus first quarter 2014 mainly due to core conversion expenses in fourth quarter 2014 related to the Riverside merger and a change in trust account tax preparation accruals for trust accounts in first quarter 2015.

Professional fees, including merger and acquisition related expenses, decreased $225,000 versus fourth quarter 2014, and increased $31,000 versus first quarter 2014. Fourth quarter 2014 expenses included consulting and legal fees related to the Riverside merger.

Loan related expenses increased $84,000 versus fourth quarter 2014 and increased $109,000 versus first quarter 2014. The comparative increase to both quarters was mainly due to the write-down and increased expense for delinquent real estate taxes associated with OREO properties in first quarter 2015.

The effective income tax rates for first quarter 2015, fourth quarter 2014 and first quarter 2014 were 29.90%, 15.41% and 28.07%, respectively.

Loans

Net loans receivable increased $3.4 million during first quarter 2015 to $676.7 million at March 31, 2015, compared with $673.3 million at December 31, 2014, and increased $230.2 million compared with $446.5 million at March 31, 2014. The year-over-year increase includes loans acquired with a fair value of $196.3 million from the Riverside Bank transaction completed in the fourth quarter 2014.

Asset Quality

Non-performing assets increased $4.0 million during first quarter 2015 to $14.9 million, or 1.7% of assets at March 31, 2015, from $10.9 million, or 1.3% of assets at December 31, 2014, and increased $6.3 million from $8.5 million, or 1.5% of assets, at March 31, 2014.

The amount of total impaired and potential problem loans improved to $30.9 million (4.53% of gross loans receivable) during first quarter 2015, compared to $31.7 million, or 4.67% of gross loans receivable at December 31, 2014, and increased $6.3 million from $24.6 million, or 5.46% of gross loans receivable at March 31, 2014.

Accruing loans receivable 30-to-89 days past due increased $1.4 million during first quarter 2015 to $5.6 million, or 0.82% of gross loans receivable, from $4.1 million, or 0.61% of gross loans receivable at December 31, 2014, and increased $1.5 million versus March 31, 2014.

Provision for loan loss expense for the quarter was negative and reflects recoveries of $460,000 for first quarter 2015 versus provision expense of $165,000 for fourth quarter 2014 and $337,000 for first quarter 2014. Excluding these recoveries, provision expense would have been approximately $260,000 for the first quarter 2015. Net loan recoveries were $24,000 for the first quarter 2015, while there were net charge-offs of $190,000 and $127,000 for fourth quarter 2014 and first quarter 2014, respectively. Reserve coverage, as measured by the ratio of the allowance for loan losses to gross loans, was 0.76% for the first quarter 2015, versus 0.79% for fourth quarter 2014 and 1.09% for first quarter 2014.

Salisbury endeavors to work constructively to resolve its non-performing loan issues with customers. Substantially all non-performing loans are collateralized with real estate and the repayment of such loans is largely dependent on the return of such loans to performing status or the liquidation of the underlying real estate collateral.

Capital

Both Salisbury and the Bank's regulatory capital ratios remain in compliance with regulatory "well capitalized" requirements. At March 31, 2015, Salisbury's Tier 1 leverage and total risk-based capital ratios were 10.14% and 14.09%, respectively. The Bank's Tier 1 leverage and total risk-based capital ratios were 9.13% and 12.98%, respectively, compared with regulatory "well capitalized" minimums of 5.00% and 10.00%, respectively. March 31, 2015 risk based capital information is presented on estimated data and incorporates the implementation of Basel III.

At March 31, 2015, Salisbury's assets totaled $865 million. Book value and tangible book value per common share were $31.96 and $26.33, respectively. Tangible book value excludes goodwill and core deposit intangibles.

In August 2011, Salisbury received $16 million of capital from the U.S. Treasury's Small Business Lending Fund (the "SBLF") program. The SBLF program was established to encourage lending to small businesses by providing Tier 1 capital to qualified community banks with assets of less than $10 billion. To date, Salisbury has used this capital to increase its portfolio of qualified small business loans by $42.6 million and to augment its regulatory capital ratios.

First Quarter 2015 Dividends on Common Shares

The Board of Directors of Salisbury declared a $0.28 per common share quarterly cash dividend at their April 24, 2015 meeting. The dividend will be paid on May 29, 2015 to shareholders of record as of May 15, 2015.

Background

Salisbury Bancorp, Inc. is the parent company of Salisbury Bank and Trust Company, a Connecticut chartered commercial bank serving the communities of northwestern Connecticut and proximate communities in New York and Massachusetts, since 1848, through full service branches in Canaan, Lakeville, Salisbury and Sharon, Connecticut; Great Barrington, South Egremont and Sheffield, Massachusetts; and Dover Plains, Fishkill, Millerton, Newburgh, Poughkeepsie, and Red Oaks Mill, New York. The Bank offers a full complement of consumer and business banking products and services as well as trust and wealth advisory services.

Forward-Looking Statements

Statements contained in this news release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and expectations of management as well as the assumptions and estimates made by management using information currently available to management. Since these statements reflect the views of management concerning future events, these statements involve risks, uncertainties and assumptions, including among others: changes in market interest rates and general and regional economic conditions; changes in government regulations; changes in accounting principles; and the quality or composition of the loan and investment portfolios and other factors that may be described in Salisbury's quarterly reports on Form 10-Q and its annual report on Form 10-K, each filed with the Securities and Exchange Commission, which are available at the Securities and Exchange Commission's internet website ( www.sec.gov ) and to which reference is hereby made. Therefore, actual future results may differ materially from results discussed in the forward-looking statements.

Salisbury Bancorp, Inc. and Subsidiary
CONSOLIDATED BALANCE SHEETS
 
(in thousands, except share data)   March 31, 2015 (unaudited) December 31, 2014  
ASSETS    
Cash and due from banks $ 15,094 $ 13,280
Interest bearing demand deposits with other banks 37,806 22,825
Total cash and cash equivalents 52,900 36,105
Securities    
 Available-for-sale at fair value 81,179 91,312
 Federal Home Loan Bank of Boston stock at cost 3,515 3,515
Loans held-for-sale 328 568
Loans receivable, net (allowance for loan losses: $5,182 and $5,358) 676,734 673,330
Other real estate owned 875 1,002
Bank premises and equipment, net 14,261 14,431
Goodwill 12,552 12,552
Intangible assets (net of accumulated amortization: $2,427 and $2,258) 2,821 2,990
Accrued interest receivable 2,356 2,334
Cash surrender value of life insurance policies 13,406 13,314
Deferred taxes 2,569 2,428
Other assets  1,541  1,546
 Total Assets $ 865,037 $ 855,427
LIABILITIES and SHAREHOLDERS' EQUITY    
Deposits    
 Demand (non-interest bearing) $ 163,387 $ 161,386
 Demand (interest bearing) 115,099 117,169
 Money market 173,492 174,274
 Savings and other 131,794 121,387
 Certificates of deposit 141,138 141,210
 Total deposits 724,910 715,426
Repurchase agreements 3,278 4,163
Federal Home Loan Bank of Boston advances 28,403 28,813
Capital lease liability 423 424
Accrued interest and other liabilities 4,812 4,780
 Total Liabilities 761,826 753,606
Shareholders' Equity    
 Preferred stock -- $.01 per share par value    
 Authorized: 25,000; Issued: 16,000 (Series B);    
 Liquidation preference: $1,000 per share 16,000 16,000
 Common stock -- $.10 per share par value    
 Authorized: 5,000,000 and 3,000,000;    
 Issued: 2,728,516 and 2,720,766 273 272
Paid-in capital 41,231 41,077
Retained earnings 44,110  42,677
Unearned compensation - restricted stock awards (271) (313)
Accumulated other comprehensive income 1,868 2,108
 Total Shareholders' Equity 103,211 101,821
 Total Liabilities and Shareholders' Equity $ 865,037 $ 855,427
     
 
Salisbury Bancorp, Inc. and Subsidiary
CONSOLIDATED STATEMENTS OF INCOME (unaudited)
 
Periods ended March 31, Three months ended
(in thousands, except per share amounts) 2015 2014
Interest and dividend income    
Interest and fees on loans $7,922 $4,596
Interest on debt securities     
Taxable 326 381
Tax exempt 390 445
Other interest and dividends 33 21
Total interest and dividend income 8,671 5,443
Interest expense    
Deposits 444 351
Repurchase agreements 1 1
Capital lease 18 18
Federal Home Loan Bank of Boston advances 282 298
Total interest expense 745 668
Net interest and dividend income 7,926 4,775
(Benefit) provision for loan losses (200) 337
Net interest and dividend income after (benefit) provision for loan losses 8,126 4,438
Non-interest income    
Gains on sales of available-for-sale securities, net 175 --
Trust and wealth advisory 822 779
Service charges and fees 731 542
Gains on sales of mortgage loans, net 94 11
Mortgage servicing, net (40) 28
Other  114 78
Total non-interest income 1,896 1,438
Non-interest expense    
Salaries 2,540 1,844
Employee benefits 1,005 741
Premises and equipment  908 673
Data processing 474 399
Professional fees 650 358
Collections and OREO 244 135
FDIC insurance 198 98
Marketing and community support 110 113
Amortization of core deposit intangibles 169 56
Merger and acquisition related expenses -- 261
Other 537 432
Total non-interest expense 6,835 5,110
Income before income taxes 3,187 766
Income tax provision 953 215
Net income $2,234 $551
Net income available to common shareholders $2,194 $505
     
Basic earnings per common share $0.81 $0.29
Diluted earnings per common share 0.80 0.29
Common dividends per share 0.28 0.28
           
           
Salisbury Bancorp, Inc. and Subsidiary
SELECTED CONSOLIDATED FINANCIAL DATA (unaudited)
 
At or for the three month periods ended          
(in thousands, except per share amounts and ratios) Q1 2015 Q4 2014 Q3 2014 Q2 2014 Q1 2014
Total assets $865,037 $855,427 $638,089 $621,476 $589,771
Loans receivable, net 676,734 673,330 461,913 456,627 446,518
Total securities 84,694 94,827 88,960 92,884 98,015
Deposits 724,910 715,426 522,294 507,361 477,512
FHLBB advances 28,403 28,813 29,218 29,619 30,017
Shareholders' equity 103,211 101,821 75,516 75,000 74,001
Wealth assets under management 384,574 385,316 416,510 429,093 439,951
Non-performing loans 14,000 9,890 8,611 8,379 8,149
Non-performing assets 14,875 10,892 8,945 8,757 8,527
Accruing loans past due 30-89 days 5,564 4,128 1,294 2,306 4,021
Net interest and dividend income 7,926 5,717 4,754 4,905 4,775
Net interest and dividend income, tax equivalent 8,238 6,038 5,075 5,227 5,104
(Benefit) provision for loan losses (200) 165 318 314 337
Non-interest income 1,896 1,579 1,553 1,682 1,438
Non-interest expense 6,835 6,852 5,108 5,068 5,110
Income before income taxes 3,187 279 881 1,205 766
Income tax provision 953 43 113 239 215
Net income 2,234 236 768 966 551
Net income available to common shareholders 2,194 196 728 926 505
           
Per share data          
Basic earnings per common share $0.81 $0.10 $0.43 $0.54 $0.29
Diluted earnings per common share 0.80 0.10 0.43 0.54 0.29
Dividends per common share 0.28 0.28 0.28 0.28 0.28
Book value per common share 31.96 31.54 34.74 34.44 33.90
Tangible book value per common share - Non-GAAP (1) 26.33 25.84 28.50 28.15 27.85
           
Common shares outstanding at end of period 2,729 2,721 1,713 1,713 1,711
Weighted average common shares outstanding, to calculate basic earnings per share  2,699 1,977 1,693 1,691 1,691
Weighted average common shares outstanding, to calculate diluted earnings per share  2,716 1,981 1,693 1,691 1,691
           
Profitability ratios          
Net interest margin (tax equivalent) 4.11% 3.68% 3.39% 3.74% 3.72%
Efficiency ratio (2) 65.45 77.84 75.92 72.35 77.11
Non-interest income to operating revenue 17.84 21.65 24.62 25.54 23.14
Effective income tax rate 29.9 15.41 12.82 19.85 28.07
Return on average assets 1.03 0.11 0.45 0.62 0.35
Return on average common shareholders' equity 10.22 1.18 4.85 6.32 3.53
           
Credit quality ratios          
Net charge-offs to average loans receivable, gross -0.01% 0.14% 0.03% 0.09% 0.12%
Non-performing loans to loans receivable, gross 2.05 1.46 1.84 1.82 1.81
Accruing loans past due 30-89 days to loans receivable, gross 0.82 0.61 0.28 0.50 0.89
Allowance for loan losses to loans receivable, gross 0.76 0.79 1.15 1.11 1.09
Allowance for loan losses to non-performing loans 37.02 54.18 62.52 60.89 60.05
Non-performing assets to total assets 1.72 1.27 1.40 1.41 1.45
           
Capital ratios          
Common shareholders' equity to assets 10.08% 10.03% 9.33% 9.49% 9.83%
Tangible common shareholders' equity to tangible assets - Non-GAAP (1) 8.45 8.37 7.78 7.90 8.22
Tier 1 leverage capital 10.14 12.31 9.85 10.50 10.65
Total risk-based capital (3) 14.09 14.29 16.27 16.11 16.42
 
(1)  Refer to schedule labeled "Supplemental Information – Non-GAAP Financial Measures."
(2) Calculated using SNL's methodology: Noninterest expense before OREO expense, amortization of intangibles, and goodwill impairments as a percent of net interest income (fully taxable equivalent) and noninterest revenues, excluding gains from securities transactions and nonrecurring FHLBB prepayment fees and litigation expenses.
(3)   The ratios presented are estimated for March 31, 2015 and actual for the remaining periods presented.
 
 
Salisbury Bancorp, Inc. and Subsidiary
SUPPLEMENTAL INFORMATION – Non-GAAP Financial Measures (unaudited)
 
At or for the quarters ended
(in thousands, except per share amounts and ratios) Q1 2015 Q4 2014 Q3 2014 Q2 2014 Q1 2014
Shareholders' Equity $ 103,211 $ 101,821 $ 75,516 $ 75,000 $ 74,001
Less: Preferred Stock (16,000) (16,000) (16,000) (16,000) (16,000)
Common Shareholders' Equity 87,211 85,821 59,516 59,000 58,001
Less: Goodwill (12,552) (12,552) (9,829) (9,829) (9,829)
Less: Intangible assets (2,821) (2,990) (872) (946) (520)
Tangible Common Shareholders' Equity $ 71,838 $ 70,279 $ 48,815 $ 48,225 $ 47,652
Total Assets $ 865,037 $ 855,427 $ 638,089 $ 621,476 $ 589,771
Less: Goodwill (12,552) (12,552) (9,829) (9,829) (9,829)
Less: Intangible assets (2,821) (2,990) (872) (946) (520)
Tangible Total Assets $ 849,664 $839,885 $ 627,388 $ 610,701 $ 579,422
Common Shares outstanding 2,729 2,721 1,713 1,713 1,711
           
Book value per Common Share – GAAP $ 31.96 $ 31.54 $ 34.74 $ 34.44 $ 33.90
Tangible book value per Common Share - Non-GAAP 26.33 25.84 28.50 28.15 27.85
           
Common Shareholders' Equity to Assets – GAAP 10.08% 10.03% 9.33% 9.49% 9.83%
Tangible Common Shareholders' Equity to Tangible Assets – Non-GAAP 8.45 8.37 7.78 7.90 8.22
           
Non-interest expense $ 6,835 $ 6,852 $ 5,108 $ 5,068 $ 5,110
Less: Amortization of core deposit intangibles (169) (97) (75) (63) (56)
Less: Foreclosed property expense (148) (114) (1) (5) (10)
Less: Strategic initiatives -- (1,596) (197) (90) (301)
Operating expenses $ 6,518 $ 5,045 $ 4,835 $ 4,910 $ 4,743
Net interest and dividend income, tax equivalent $ 8,238 $ 6,038 $ 5,075 $ 5,227 $ 5,104
Non-interest income 1,896 1,579 1,553 1,682 1,438
Gains on securities, net (175) -- -- -- --
Operating revenue $ 9,959 $ 7,617 $ 6,628 $ 6,909 $ 6,542
Efficiency Ratio less strategic initiatives 65.45% 66.19% 72.94% 71.07% 72.49%
           

Salisbury Contact: Richard J. Cantele, Jr. President and Chief Executive Officer 860-435-9801

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 50

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 36

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 67

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 77

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 46

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 95

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Galien Recognizes Kerry for Transformative Global Health Work

Updated Category News Views 75

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 109

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
Joshua Davenport: Celebrating 25 Years in Healthcare

Updated Category News Views 73

25 Years Strong: Davenport's Journey in Healthcare Not every day you celebrate someone who's spent a quarter of a century in the trenches of healthcare. Joshua L. Davenport, RN, isn't just clocking years; he's built a legacy in emergency nursing and occupational health that speaks volumes about resilience and commitment to others. From Humble Beginnings to Health...

Continue Reading

Top 5 Most Recently Viewed Articles

LandingAI's Significant Achievement at Snowflake Conference

Updated Category News Views 140

LandingAI Recognized as Partner of the Year LandingAI has received notable recognition at the Snowflake annual user conference for its exceptional contributions to the data cloud landscape. This acknowledgement highlights how LandingAI not only stands out in the tech industry but also pushes the boundaries of what's possible with artificial intelligence and data...

Continue Reading
Aventura Mall Tops USA Shopping Malls Again in 2026

Updated Category News Views 22

A Second Victory for Aventura Mall Well, folks, here we are again; Aventura Mall has pulled it off for a second consecutive year, grabbing the coveted 'Best Mall in the United States' title from the esteemed USA Today 10Best Readers’ Choice Awards. Now, before you roll your eyes, let's acknowledge that this ain't just a shiny plaque on the wall; it's a testament to how...

Continue Reading
Critical Metals Corp Reveals $3 Billion Valuation for Tanbreez Project

Updated Category News Views 500

Insights into Critical Metals Corp’s Tanbreez Project Critical Metals Corp (NASDAQ: CRML) recently announced an independent Preliminary Economic Assessment (PEA) for its renowned Tanbreez Project, located in Southern Greenland. This project stands out as one of the world's largest rare earth deposits, boasting a significant mineral resource of 4.7 billion metric tons of...

Continue Reading
Salesforce's Promising Future: What Investors Need to Know

Updated Category News Views 100

Salesforce's Resilient Position Amid Economic Shifts As investors navigate the current economic landscape, many are focused intently on immediate data rather than the implications for the future. With an election looming and a new earnings season underway, there's much to consider. The timeout on interest rate deliberations further complicates the financial scene, as the...

Continue Reading
Exciting Announcements for Garden Centres Canada Summit 2025

Updated Category News Views 131

Garden Centres Canada Summit 2025: An Overview The Canadian Nursery Landscape Association (CNLA) is excited to announce the upcoming Garden Centres Canada Summit 2025. This highly anticipated event will take place in Winnipeg, uniting garden centre operators, retail professionals, and industry leaders. Event Details and Schedule The Garden Centres Canada Summit is a...

Continue Reading